P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma. (12th March 2014) - Dargel, C; Bassani-Sternberg, M; Krebs, K; Wilde, S; Schendel, D; Busch, DH; Mann, M; Protzer, U